...
首页> 外文期刊>Preventive Medicine: An International Journal Devoted to Practice and Theory >Improving medication adherence in hypertensive patients: A scoping review
【24h】

Improving medication adherence in hypertensive patients: A scoping review

机译:改善高血压患者的药物依从性:审查评论

获取原文
获取原文并翻译 | 示例

摘要

In recent years, interest in medication adherence has greatly increased. Adherence has been particularly well studied in the context of arterial hypertension treatment. Numerous interventions have addressed this issue, however, the effort to improve adherence has been often frustrating and frequently disorganized. The aim of present study was to perform a scoping review of medication adherence interventions in hypertensive patients, so that a clear overview was achieved. Moreover, an evidence-based categorization of interventions was developed. The review was performed according to the PRISMA-ScR statement. MEDLINE and Web of Science were searched, and studies published from database inception until August 17, 2020 were included. A total of 2994 non-duplicate studies were retrieved. After screening and eligibility phases, a total of 45 articles were included. Studies were analyzed regarding their design, participant characteristics and management of adherence strategies employed. Furthermore, medication adherence and blood pressure outcomes, as well as adherence measuring tools were evaluated. Each study?s intervention was then categorized using a novel evidence-based system of categorization, derived from the conceptual clustering framework used in machine learning. This work is an important step in pushing for better informed and more efficient future research efforts, both by providing an overview of the research field and by creating a new, evidence-based intervention categorization tool. It also provides valuable information to clinicians about medication adherence to antihypertensive therapy.
机译:近年来,人们对药物依从性的兴趣大大增加。在动脉高血压治疗中,对依从性的研究尤其充分。许多干预措施都解决了这一问题,然而,改善遵守情况的努力往往令人沮丧,而且往往没有条理。本研究的目的是对高血压患者的药物依从性干预进行范围界定审查,以便获得清晰的概述。此外,还对干预措施进行了循证分类。审查是根据PRISMA ScR声明进行的。搜索MEDLINE和科学网,包括从数据库开始到2020年8月17日发表的研究。共检索到2994项非重复研究。在筛选和资格审查阶段后,共纳入45篇文章。对研究的设计、参与者特征和所采用的依从策略的管理进行了分析。此外,还评估了药物依从性和血压结果,以及依从性测量工具。每项研究?然后,根据机器学习中使用的概念聚类框架,使用一种新的基于证据的分类系统对患者的干预进行分类。这项工作是推动更知情、更有效的未来研究工作的重要一步,既可以提供研究领域的概述,也可以创建新的基于证据的干预分类工具。它还为临床医生提供了关于抗高血压治疗药物依从性的宝贵信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号